These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39053098)

  • 1. Plasma sphingolipids, dopaminergic degeneration and clinical progression in idiopathic Parkinson's disease.
    Yang R; He C; Zhang P; Li Y; Rong S; Chen X; Qi Q; Gao Z; Chi J; Wang L; Cai M; Zhang Y
    Parkinsonism Relat Disord; 2024 Sep; 126():107071. PubMed ID: 39053098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of striatal dopamine transporter binding with motor and non-motor symptoms in early Parkinson's disease.
    Yang Z; Xie Y; Dou K; Yang L; Xie A
    Clin Transl Sci; 2023 Jun; 16(6):1021-1038. PubMed ID: 36915231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson's disease patients and healthy controls.
    Wang C; Zhou C; Guo T; Jiaerken Y; Yang S; Xu X; Hu L; Huang P; Xu X; Zhang M
    BMC Med; 2023 Jul; 21(1):272. PubMed ID: 37491235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy.
    Sakakibara S; Hashimoto R; Katayama T; Kenjyo M; Yokokawa Y; Saito Y; Hirakawa A; Ito M; Nakamura T; Hara K; Hashizume A; Aiba I; Inukai A; Katsuno M
    J Parkinsons Dis; 2020; 10(1):123-130. PubMed ID: 31707374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson's Disease.
    Muñoz-Delgado L; Labrador-Espinosa MÁ; Macías-García D; Jesús S; Benítez Zamora B; Fernández-Rodríguez P; Adarmes-Gómez AD; Reina Castillo MI; Castro-Labrador S; Silva-Rodríguez J; Carrillo F; García Solís D; Grothe MJ; Mir P
    Mov Disord; 2023 May; 38(5):755-763. PubMed ID: 36912400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bidirectional Correlations Between Dopaminergic Function and Motivation in Parkinson's Disease.
    Hinkle JT; Mills KA; Perepezko K; Pontone GM
    J Geriatr Psychiatry Neurol; 2022 May; 35(3):353-362. PubMed ID: 33622073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal decline in striatal dopamine transporter binding in Parkinson's disease: associations with apathy and anhedonia.
    Costello H; Yamamori Y; Reeves S; Schrag AE; Howard R; Roiser JP
    J Neurol Neurosurg Psychiatry; 2023 Oct; 94(10):863-870. PubMed ID: 37221053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson's Disease Motor Progression.
    Jackson H; Anzures-Cabrera J; Taylor KI; Pagano G; ;
    Front Neurosci; 2021; 15():765765. PubMed ID: 34966256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
    Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
    Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessments.
    Rahmim A; Salimpour Y; Jain S; Blinder SA; Klyuzhin IS; Smith GS; Mari Z; Sossi V
    Neuroimage Clin; 2016; 12():e1-e9. PubMed ID: 27995072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic properties in functional connectivity changes and striatal dopamine deficiency in Parkinson's disease.
    Asendorf AL; Theis H; Tittgemeyer M; Timmermann L; Fink GR; Drzezga A; Eggers C; Ruppert-Junck MC; Pedrosa DJ; Hoenig MC; van Eimeren T
    Hum Brain Mapp; 2024 Jul; 45(10):e26776. PubMed ID: 38958131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal dopamine transporter availability and individual clinical course within the 1-year follow-up of deep brain stimulation of the subthalamic nucleus in patients with Parkinson's disease.
    Löser J; Luthardt J; Rullmann M; Weise D; Sabri O; Meixensberger J; Hesse S; Winkler D
    J Neurosurg; 2021 Nov; 135(5):1429-1435. PubMed ID: 33607613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease.
    Liu R; Umbach DM; Tröster AI; Huang X; Chen H
    Parkinsonism Relat Disord; 2020 Mar; 72():23-30. PubMed ID: 32092703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Uric Acid in LRRK2 Related Parkinson's Disease: Longitudinal Data from the PPMI Study.
    Bougea A; Koros C; Papagiannakis N; Simitsi AM; Prentakis A; Papadimitriou D; Pachi I; Antonelou R; Angelopoulou E; Beratis I; Bozi M; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    J Parkinsons Dis; 2021; 11(2):633-640. PubMed ID: 33682725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort.
    Marek K; Chowdhury S; Siderowf A; Lasch S; Coffey CS; Caspell-Garcia C; Simuni T; Jennings D; Tanner CM; Trojanowski JQ; Shaw LM; Seibyl J; Schuff N; Singleton A; Kieburtz K; Toga AW; Mollenhauer B; Galasko D; Chahine LM; Weintraub D; Foroud T; Tosun-Turgut D; Poston K; Arnedo V; Frasier M; Sherer T;
    Ann Clin Transl Neurol; 2018 Dec; 5(12):1460-1477. PubMed ID: 30564614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's Disease.
    Trinh I; Muralidhar A; Yang J; Phielipp N
    Mov Disord Clin Pract; 2023 Jun; 10(6):896-902. PubMed ID: 37332639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Neuropsychiatric Symptoms of Parkinson's Disease with Measures of Striatal Dopaminergic Deficiency.
    Bishnoi R; Badir MC; Surya S; Youssef NA
    Curr Alzheimer Res; 2021; 18(6):499-504. PubMed ID: 34455969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease.
    Hinkle JT; Perepezko K; Mills KA; Mari Z; Butala A; Dawson TM; Pantelyat A; Rosenthal LS; Pontone GM
    Parkinsonism Relat Disord; 2018 Oct; 55():8-14. PubMed ID: 30146185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glucocerebrosidase mutations and uric acid levels in Parkinson's disease: A 3-years investigation of a potential biomarker".
    Mozafar M; Kazemian S; Hoseini E; Mohammadi M; Alimoghadam R; Shafie M; Mayeli M;
    Clin Park Relat Disord; 2023; 8():100177. PubMed ID: 36590455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of peripheral neutrophils and lymphocytes in early untreated Parkinson's disease: an 8-year follow-up study.
    Kim R; Kang N; Byun K; Park K; Jun JS
    J Neurol Neurosurg Psychiatry; 2023 Dec; 94(12):1040-1046. PubMed ID: 37451695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.